Inflammasome is a central player in B cell development and homing.
Journal
Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
31
08
2022
revised:
16
11
2022
accepted:
16
11
2022
entrez:
30
11
2022
pubmed:
1
12
2022
medline:
3
12
2022
Statut:
epublish
Résumé
Whereas the role of the nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing protein (NLRP) 3 pathway in innate immunity has been extensively studied, little attention has been paid to its contribution to adaptive immunity. Studies in animal models and human subjects have shown the contribution of NLRP3 to the T cell compartment, and its role in B lymphocyte functions has been proposed. Here, we report that ablation of
Identifiants
pubmed: 36450446
pii: 6/2/e202201700
doi: 10.26508/lsa.202201700
pmc: PMC9713303
pii:
doi:
Substances chimiques
Inflammasomes
0
NLR Family, Pyrin Domain-Containing 3 Protein
0
Receptors, Chemokine
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2022 Hsu and Zouali.
Références
Nature. 2013 Jan 31;493(7434):684-8
pubmed: 23263181
J Immunol. 2012 Aug 15;189(4):2006-16
pubmed: 22753929
J Exp Med. 2007 Jan 22;204(1):153-60
pubmed: 17210730
J Exp Med. 2002 Jan 21;195(2):181-8
pubmed: 11805145
Annu Rev Immunol. 2009;27:229-65
pubmed: 19302040
Nat Immunol. 2015 Aug;16(8):859-70
pubmed: 26098997
Front Immunol. 2017 Nov 09;8:1504
pubmed: 29170665
J Vis Exp. 2010 Jan 28;(35):
pubmed: 20110936
Immunol Rev. 2010 Sep;237(1):22-42
pubmed: 20727027
Trends Biochem Sci. 2016 Dec;41(12):1012-1021
pubmed: 27669650
J Immunol. 1983 Aug;131(2):801-5
pubmed: 6602846
Sci Rep. 2019 Mar 11;9(1):4034
pubmed: 30858427
Nat Rev Immunol. 2019 Aug;19(8):477-489
pubmed: 31036962
Development. 2019 Aug 1;146(15):
pubmed: 31371526
Science. 1999 Dec 10;286(5447):2156-9
pubmed: 10591647
Immunity. 1996 Dec;5(6):505-11
pubmed: 8986711
Ann N Y Acad Sci. 1995 Sep 29;764:207-21
pubmed: 7486526
Front Immunol. 2019 Jul 15;10:1566
pubmed: 31379813
Nat Immunol. 2015 Dec;16(12):1274-81
pubmed: 26437243
Mol Cell Biol. 2008 Apr;28(8):2815-24
pubmed: 18285461
J Biol Chem. 2019 Nov 22;294(47):17951-17961
pubmed: 31597697
J Exp Med. 2013 Dec 16;210(13):2887-902
pubmed: 24323359
J Exp Med. 2018 Feb 5;215(2):399-413
pubmed: 29326381
Immunol Today. 1992 Feb;13(2):41-3
pubmed: 1575891
Science. 2016 Jun 17;352(6292):aad1210
pubmed: 27313051
J Exp Med. 2000 Jul 17;192(2):271-80
pubmed: 10899913
J Immunol. 2009 Dec 15;183(12):8061-7
pubmed: 20007575
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15324-9
pubmed: 21876127
Annu Rev Immunol. 2001;19:595-621
pubmed: 11244048
Science. 1999 Dec 10;286(5447):2098-102
pubmed: 10617422
J Clin Invest. 2015 Jun;125(6):2203-10
pubmed: 25938781
Immunity. 2001 May;14(5):617-29
pubmed: 11371363
Clin Immunol. 2005 Jan;114(1):17-26
pubmed: 15596405
J Leukoc Biol. 2004 Sep;76(3):709-18
pubmed: 15197239
Genes Dev. 1995 Jun 1;9(11):1377-87
pubmed: 7797077
J Exp Med. 2009 Aug 3;206(8):1803-16
pubmed: 19581408
J Immunol Methods. 1986 Jun 10;90(1):105-10
pubmed: 3486920
J Immunol. 2005 Dec 1;175(11):7719-27
pubmed: 16301682